This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: University of Cincinnati. Active years: 2021-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2024
Title: Innovations by Rui Su in Cancer Treatment
Introduction
Rui Su is an accomplished inventor based in Cincinnati, Ohio, known for his significant contributions to the field of cancer treatment. With a focus on innovative pharmaceutical compositions, he has developed methods aimed at improving the lives of patients suffering from glioma and leukemia. His work has led to the filing of two patents that showcase his dedication to advancing medical science.
Latest Patents
Rui Su's latest patents include compositions and methods for treating patients suffering from glioma or leukemia. These patents provide pharmaceutical compositions, kits, and methods for treating tumors such as glioma and cancers like leukemia with (R)-2-hydroxyglutarate (R-2HG). The therapeutic regimens outlined in these patents include the treatment of patients with a MYC-signaling inhibitor, followed by or concurrently with treatment using R-2HG, and optionally other chemotherapeutic agents.
Career Highlights
Rui Su is affiliated with the University of Cincinnati, where he continues to engage in groundbreaking research. His work is characterized by a commitment to developing effective treatments for serious health conditions, particularly in oncology. His innovative approaches have garnered attention in the medical community, contributing to the advancement of cancer therapies.
Collaborations
Rui Su collaborates with Jianjun Chen, a fellow researcher, to further enhance the impact of their work in the field of cancer treatment. Their partnership exemplifies the importance of teamwork in scientific research and innovation.
Conclusion
Rui Su's contributions to cancer treatment through his innovative patents reflect his dedication to improving patient outcomes. His work at the University of Cincinnati continues to pave the way for advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
